IL6 and metabolic syndrome: Through toll-like receptor activation, sustained inflammatory signaling (e.g., IL-6, TNF-α, CRP), and endotoxin release, these infections may chronically disrupt immunometabolic homeostasis, potentially triggering a MetS-like phenotype in previously healthy individuals [17].